Davis Aaron I.
Insider CIK 1465914 · MRTX Director, 10% owner · PMVP · ODT Director, 10% owner · RAIN Director, 10% owner · PAND 10% owner · ITOS Director, 10% owner · TNGX Director, 10% owner · TYRA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-11-06 | 2024-11-07 | 3,080,000 | $3.14 | $9.67M | 3,610,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-10-25 | 2024-10-28 | 633,000 | $6.87 | $4.35M | 6,690,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-10-22 | 2024-10-23 | 250,000 | $6.78 | $1.70M | 7,323,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-10-21 | 2024-10-23 | 625,000 | $7.05 | $4.41M | 7,573,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | J Other deriv | 2024-09-03 | 2024-09-05 | 65,000 | — | $0 | 65,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-02 | 2024-07-02 | 95,000 | $8.68 | $824.6K | 108,793 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 110,731 | $8.87 | $982.2K | 203,793 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-06-28 | 2024-07-02 | 29,000 | $8.57 | $248.5K | 314,524 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 24,200 | — | $0 | 24,200 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-06-07 | 2024-06-07 | 77,000 | $6.88 | $529.8K | 343,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-06-06 | 2024-06-07 | 63,000 | $7.24 | $456.1K | 420,524 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award | 2024-05-10 | 2024-05-14 | 1,142,857 | $17.50 | $20.00M | 2,946,915 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-05-03 | 2024-05-03 | 60,000 | $7.61 | $456.6K | 483,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-05-02 | 2024-05-03 | 75,000 | $7.56 | $567.0K | 543,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2024-05-01 | 2024-05-03 | 75,000 | $7.43 | $557.3K | 618,524 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2024-02-06 | 2024-02-08 | 705,280 | $13.01 | $9.18M | 705,280 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2024-02-06 | 2024-02-08 | 63,412 | $13.01 | $825.0K | 85,939 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 35,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | D To issuer deriv | 2024-01-26 | 2024-01-26 | 20,000 | — | $0 | 0 | SEC↗ |
| RAIN Rain Oncology Inc. | U Tender | 2024-01-26 | 2024-01-26 | 79,726 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 11,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 25,000 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-23 | 7,520 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 1,413,475 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 3,578,036 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 332,809 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 4,444 | — | $0 | 6,808 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 43,073 | — | $0 | 11,252 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-23 | 6,808 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 287,866 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 30,518 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 3,201,440 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 203,754 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 3,135,966 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-12-29 | 2024-01-03 | 6,808 | $58.75 | $400.0K | 54,325 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-16 | 2023-10-17 | 500,000 | $6.84 | $3.42M | 8,198,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-16 | 2023-10-17 | 500,000 | $6.84 | $3.42M | 8,198,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-13 | 2023-10-17 | 750,000 | $7.07 | $5.30M | 7,698,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-13 | 2023-10-17 | 750,000 | $7.07 | $5.30M | 7,698,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2023-10-09 | 2023-10-11 | 175,000 | $9.97 | $1.74M | 6,948,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2023-10-09 | 2023-10-11 | 50,000 | $9.91 | $495.5K | 693,524 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2023-08-23 | 2023-08-25 | 219,638 | $16.87 | $3.71M | 1,804,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2023-08-23 | 2023-08-25 | 95,516 | $15.63 | $1.49M | 2,023,696 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2023-08-23 | 2023-08-25 | 34,846 | $14.19 | $494.5K | 2,119,212 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2023-08-11 | 2023-10-11 | 2,340,579 | $5.15 | $12.05M | 2,340,579 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2023-08-11 | 2023-10-11 | 475,000 | $5.15 | $2.45M | 743,542 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy deriv | 2023-08-11 | 2023-08-15 | 2,340,579 | $5.15 | $12.05M | 2,340,597 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 475,000 | $5.15 | $2.45M | 743,542 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 57,533 | $27.80 | $1.60M | 287,866 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 1,201,440 | $27.80 | $33.40M | 3,201,440 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 1,201,440 | $27.80 | $33.40M | 3,201,440 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 57,533 | $27.80 | $1.60M | 287,866 | SEC↗ |
| RAIN Rain Oncology Inc. | A Award deriv | 2023-08-09 | 2023-08-11 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 22,383 | — | $0 | 22,383 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2023-06-06 | 2023-06-08 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RAIN Rain Oncology Inc. | S Sale | 2023-05-22 | 2023-05-24 | 995,000 | $1.25 | $1.24M | 1,152,212 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2023-02-10 | 2023-02-13 | 65,568 | $13.40 | $878.6K | 22,527 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | S Sale | 2023-02-09 | 2023-02-13 | 200,000 | $13.10 | $2.62M | 88,095 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2023-01-20 | 2023-01-24 | 7,520 | — | $0 | 7,520 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2023-01-20 | 2023-01-24 | 4,444 | — | $0 | 47,517 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy deriv | 2022-11-04 | 2022-11-08 | 400,000 | $5.83 | $2.33M | 3,422,489 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2022-11-04 | 2022-11-08 | 972,212 | $5.83 | $5.67M | 2,147,212 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-13 | 2022-10-13 | 70,000 | $4.65 | $325.5K | 7,123,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-12 | 2022-10-13 | 50,000 | $4.43 | $221.5K | 268,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-11 | 2022-10-13 | 117,000 | $4.25 | $497.3K | 218,524 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 17,538 | — | $0 | 17,538 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | A Award deriv | 2022-06-01 | 2022-08-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-11 | 337,109 | $18.25 | $6.15M | 2,154,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-05-11 | 2022-05-11 | 891 | $17.53 | $15.6K | 2,491,167 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-05-10 | 2022-05-11 | 95,150 | $25.18 | $2.40M | 2,496,908 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-05-10 | 2022-05-11 | 4,850 | $24.77 | $120.1K | 2,492,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-05-09 | 2022-05-11 | 200,000 | $23.47 | $4.69M | 2,592,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-05-09 | 2022-05-11 | 25,000 | $22.91 | $572.8K | 2,792,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-05-02 | 2022-05-02 | 7,300 | $26.91 | $196.4K | 2,909,758 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-05-02 | 2022-05-02 | 92,700 | $27.53 | $2.55M | 2,817,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-04-29 | 2022-05-02 | 10,000 | $28.22 | $282.2K | 3,032,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-04-29 | 2022-05-02 | 115,000 | $27.01 | $3.11M | 2,917,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-04-28 | 2022-05-02 | 150,000 | $27.40 | $4.11M | 3,042,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2022-03-23 | 2022-03-24 | 20,000 | $32.85 | $657.0K | 3,192,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2022-03-22 | 2022-03-24 | 21,300 | $31.88 | $679.0K | 3,163,358 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2022-03-22 | 2022-03-24 | 3,700 | $33.09 | $122.4K | 3,167,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2022-03-22 | 2022-03-24 | 5,000 | $33.43 | $167.2K | 3,172,058 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2022-01-14 | 2022-01-18 | 3,688 | — | $0 | 3,688 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2022-01-14 | 2022-01-18 | 2,546 | — | $0 | 43,073 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 88,054 | $41.84 | $3.68M | 3,767,405 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 11,199 | $44.44 | $497.7K | 2,517 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 3,138 | $43.36 | $136.1K | 13,716 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 29,623 | $41.84 | $1.24M | 16,854 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 7,483 | $45.48 | $340.3K | 3,717,259 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 33,297 | $44.44 | $1.48M | 3,724,742 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 9,366 | $43.36 | $406.1K | 3,758,039 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 2,517 | $45.48 | $114.5K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 731 | $50.63 | $37.0K | 46,477 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 1,682 | $49.37 | $83.0K | 47,208 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 23,353 | $47.63 | $1.11M | 48,890 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 17,173 | $50.63 | $869.5K | 3,855,459 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 39,481 | $49.37 | $1.95M | 3,872,632 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 432,903 | $47.65 | $20.63M | 3,912,113 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-11-19 | 2021-11-19 | 150,000 | $1.84 | $276.0K | 4,607,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-11-19 | 2021-11-19 | 30,000 | $1.92 | $57.6K | 445,756 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-11-18 | 2021-11-19 | 250,000 | $1.95 | $487.5K | 4,757,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-11-17 | 2021-11-19 | 600,000 | $2.17 | $1.30M | 5,007,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-11-17 | 2021-11-19 | 170,000 | $2.23 | $379.1K | 475,756 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 1,480,242 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 15,401 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 713,629 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 95,516 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 288,095 | — | $0 | 288,095 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2021-09-17 | 2021-09-17 | 625,000 | $16.00 | $10.00M | 6,323,359 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 5,698,359 | — | $0 | 5,698,359 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 16,608 | — | $0 | 16,608 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 86,097 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 3,263,986 | — | $0 | 0 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 79,726 | — | $0 | 79,726 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 3,022,489 | — | $0 | 3,022,489 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-27 | 2021-04-27 | 1,025,000 | $17.00 | $17.43M | 1,175,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-23 | 2021-04-27 | 125,000 | $16.27 | $2.03M | 150,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-23 | 2021-04-27 | 25,000 | $15.58 | $389.5K | 25,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 468,639 | $13.00 | $6.09M | 332,809 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 128,805 | $5.60 | $721.3K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 13,996 | $5.60 | $78.4K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 4 | $181.00 | $724 | 2,363,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-05 | 2021-03-09 | 13,996 | — | $0 | 267,334 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 363,000 | $181.15 | $65.76M | 2,000,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 1 | $181.00 | $181 | 267,333 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-05 | 2021-03-09 | 597,444 | — | $0 | 2,363,004 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 37,000 | $181.15 | $6.70M | 230,333 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 2,155 | — | $0 | 2,155 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2021-01-15 | 2021-01-20 | 1,475 | — | $0 | 40,527 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-12-30 | 2020-12-30 | 100,000 | $17.46 | $1.75M | 5,607,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-12-29 | 2020-12-30 | 225,000 | $17.11 | $3.85M | 5,507,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-12-28 | 2020-12-30 | 75,000 | $16.90 | $1.27M | 5,282,086 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-30 | 2020-10-30 | 37,051 | $5.60 | $207.5K | 13,996 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-30 | 2020-10-30 | 362,952 | $5.60 | $2.03M | 128,805 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-30 | 2020-10-30 | 37,050 | $202.00 | $7.48M | 216,288 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-30 | 2020-10-30 | 2 | $219.97 | $440 | 1,765,560 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-30 | 2020-10-30 | 362,952 | — | $0 | 1,765,562 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-30 | 2020-10-30 | 362,950 | $202.00 | $73.32M | 1,404,610 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-30 | 2020-10-30 | 1 | $219.97 | $220 | 253,338 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-30 | 2020-10-30 | 37,051 | — | $0 | 253,339 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 32,708 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 586,099 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 732,137 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 28,129 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 32,708 | — | $0 | 32,708 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 732,137 | — | $0 | 2,268,236 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 586,099 | — | $0 | 1,536,099 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 28,129 | — | $0 | 60,837 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-09-29 | 2020-09-30 | 122,000 | $14.08 | $1.72M | 5,207,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-09-28 | 2020-09-30 | 93,200 | $13.03 | $1.21M | 5,085,086 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | P Buy | 2020-09-25 | 2020-09-29 | 950,000 | $18.00 | $17.10M | 950,000 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-09-09 | 2020-09-09 | 81,100 | $15.20 | $1.23M | 4,991,886 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-09-08 | 2020-09-09 | 18,800 | $14.69 | $276.2K | 4,910,786 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-09-04 | 2020-09-09 | 125,100 | $14.89 | $1.86M | 4,891,986 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-08-28 | 2020-09-01 | 1,403,509 | $14.25 | $20.00M | 4,766,886 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 158,687 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-30 | 9,593,086 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 2,943,568 | — | $0 | 2,943,568 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-30 | 48,691 | — | $0 | 48,691 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 1,401,448 | $19.00 | $26.63M | 4,345,016 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-30 | 23,552 | $19.00 | $447.5K | 72,243 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2020-07-23 | 2020-10-21 | 16,608 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award deriv | 2020-07-23 | 2020-07-24 | 16,608 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 7,064,136 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 120,460 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 23,622 | — | $0 | 23,622 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 1,385,291 | — | $0 | 1,385,291 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 722,222 | $18.00 | $13.00M | 2,107,513 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2020-01-03 | 2020-01-07 | 4,000 | — | $0 | 4,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award | 2020-01-03 | 2020-01-07 | 2,000 | — | $0 | 39,052 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2019-01-17 | 2019-01-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-01-08 | 2019-01-09 | 5,000 | $53.40 | $267.0K | 37,052 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-01-08 | 2019-01-09 | 5,000 | $52.20 | $261.0K | 42,052 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-01-07 | 2019-01-09 | 8,357 | $46.29 | $386.8K | 62,052 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-01-07 | 2019-01-09 | 15,000 | $47.48 | $712.2K | 47,052 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2019-01-07 | 2019-01-09 | 16,643 | $45.47 | $756.8K | 70,409 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-12-26 | 2018-12-27 | 25,000 | $12.47 | $311.8K | 2,978,762 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-12-21 | 2018-12-27 | 75,000 | $13.47 | $1.01M | 2,953,762 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-12-21 | 2018-12-27 | 25,000 | $13.46 | $336.5K | 2,878,762 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | A Award deriv | 2018-12-06 | 2018-12-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-10-24 | 2018-10-26 | 26,824 | $14.72 | $394.8K | 2,853,762 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-03-26 | 2018-03-26 | 33,650 | $22.41 | $754.1K | 2,826,938 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-03-23 | 2018-03-26 | 42,943 | $23.96 | $1.03M | 2,793,288 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-03-22 | 2018-03-26 | 23,407 | $20.94 | $490.1K | 2,750,345 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2017-12-06 | 2017-12-08 | 416,666 | $24.00 | $10.00M | 2,726,938 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise deriv | 2017-10-03 | 2017-10-03 | 189,780 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise deriv | 2017-10-03 | 2017-10-03 | 78,186 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise | 2017-10-03 | 2017-10-03 | 78,186 | $7.86 | $614.5K | 513,630 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise | 2017-10-03 | 2017-10-03 | 189,780 | $7.86 | $1.49M | 1,227,774 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-01-06 | 2017-01-10 | 51,047 | $5.60 | $285.9K | 51,047 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-01-06 | 2017-01-10 | 2,341,786 | $5.60 | $13.11M | 2,341,786 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-06 | 2017-01-10 | 280,059 | $5.60 | $1.57M | 1,037,994 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-06 | 2017-01-10 | 6,104 | $5.60 | $34.2K | 435,444 | SEC↗ |